Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synbio TechROCO:1295 -0.40%44 Operating Margin % is 11.73% as of Dec. 2025, which is 42% below its 10-year median of 20.13. GuruFocus rates ROCO:1295 with a GF Score™ of 44/100. The stock has 10 warning signs investors should review. Among 939 Biotechnology companies, Synbio Tech ranks better than 87.54% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Synbio Tech's Operating Income for the
three
months ended in Dec. 2025 was NT$33 Mil. Synbio Tech's Revenue for the
three
months ended in Dec. 2025 was NT$285 Mil. Therefore, Synbio Tech's Operating Margin % for the quarter that ended in Dec. 2025 was 11.73%.
Warning Sign:
Synbio Tech Inc operating margin has been in a 5-year decline. The average rate of decline per year is -1.3%.
The historical rank and industry rank for Synbio Tech's Operating Margin % or its related term are showing as below:
ROCO:1295'
s Operating Margin % Range Over the Past 10 Years
Min: 13.77 Med: 20.13 Max: 21.8
Current: 19.1
ROCO:1295's Operating Margin % is ranked better than 87.54% of 939
companies
in the Biotechnology industry
Industry Median: -86.33
vs ROCO:1295: 19.10
Synbio Tech's 5-Year Average Operating Margin % Growth Rate was -1.30% per year.
Synbio Tech's Operating Income for the
three
months ended in Dec. 2025 was NT$33 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was NT$198 Mil.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Synbio Tech Operating Margin % Related Terms
Synbio Tech Operating Margin % Historical Data
* Premium members only.
The historical data trend for Synbio Tech's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1295 vs VRTX, REGN, ALNY: Operating Margin % Comparison
For the Biotechnology subindustry, Synbio Tech's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synbio Tech Operating Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Synbio Tech's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Synbio Tech's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Synbio Tech's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synbio Tech (ROCO:1295) has a Operating Margin % of 11.73% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Synbio Tech and its competitors. This is 42% below median its historical median of 20.13. Over the past decade, Synbio Tech's Operating Margin % has ranged from 13.77 to 21.80. According to the industry distribution chart, Synbio Tech ranks #117 out of 939 companies in the Biotechnology industry, placing it in the top 12.5%.
Is Synbio Tech's Operating Margin % too high?
Synbio Tech's current Operating Margin % of 11.73% is 42% below median its 10-year median of 20.13. Over the past 10 years, this metric has ranged from a low of 13.77 to a high of 21.80. Based on the distribution chart, Synbio Tech ranks #117 out of 939 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Synbio Tech has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Synbio Tech ranks #117 out of 939 companies for Operating Margin %. This places Synbio Tech in the top 13% of its industry — outperforming the majority of peers. Historically, Synbio Tech's own Operating Margin % has ranged from 13.77 to 21.80 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Synbio Tech and its competitors. Synbio Tech's current Operating Margin % is 11.73%, which is 42% below median its own 10-year median of 20.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current Operating Margin % of 11.73%. The current Operating Margin % is 11.73%, which is 42% below median its 10-year median of 20.13. Synbio Tech's overall GF Score™ is 44/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current Operating Margin % is 11.73% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
44GF Score
Get the complete analysis for ROCO:1295
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1295 has been successfully added to your 
